GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GRAL GRAIL, Inc.

Market Closed 07-17 16:00:00 EDT

72.62

+0.66

+0.92%

盘后72.62

+0.000.00%

18:49 EDT

High72.75	Low69.69	Vol413.76K
Open70.00	D1 Closing71.96	Amplitude4.25%
Mkt Cap3.12B	Tradable Cap2.82B	Total Shares42.92M
T/O29.77M	T/O Rate1.06%	Tradable Shares38.90M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":72.62,"timestamp":1784318400000,"preClose":71.96,"halted":0,"volume":413760,"hourTrading":{"tag":"盘后","latestPrice":72.62,"preClose":72.62,"latestTime":"18:49 EDT","volume":13320,"amount":967291.3699,"timestamp":1784328552379,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009171762090050179,"floatShares":38896087,"shares":42916593,"eps":-10.3,"marketStatus":"Market Closed","change":0.66,"latestTime":"07-17 16:00:00 EDT","open":70,"high":72.75,"low":69.69,"amount":29773702.051200002,"amplitude":0.042524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.3,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":71.96,"preHourTrading":{"tag":"盘前","latestPrice":70.06,"preClose":71.96,"latestTime":"09:18 EDT","volume":85,"amount":5975.559925,"timestamp":1784294296372,"change":-1.9,"changeRate":-0.026404,"amplitude":0.007504},"postHourTrading":{"tag":"盘后","latestPrice":72.62,"preClose":72.62,"latestTime":"18:49 EDT","volume":13320,"amount":967291.3699,"timestamp":1784328552379,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.926067,"impliedVol":0.8595,"impliedVolPercentile":0.2112},"requestUrl":"/m/hq/s/GRAL/tweets","defaultTab":"tweets","newsList":[{"id":"2651442688","title":"Priority Health Collaborates with Grail as the First Michigan Health Plan to Offer the Galleri® Multi-cancer Early Detection Blood Test to Employer Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442688","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442688?lang=en_us&edition=fundamental","pubTime":"2026-07-16 21:00","pubTimestamp":1784206805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA6NTCLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651645285","title":"Grail Inc : Mizuho Raises Target Price to $65 from $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2651645285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651645285?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:37","pubTimestamp":1784111876,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650451974","title":"Cancer Blood Screen Spac's Merger is Delayed by Test's Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650451974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650451974?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:24","pubTimestamp":1783628640,"startTime":"0","endTime":"0","summary":"Call Thursday's cancer test results mixed.Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4588","LU0109394709.USD","EKG","GH","PTH","GDOC","LU0320765992.SGD","GRAL","LU0889565916.HKD","LFSC","HELX","GNOM","BK4196","BK4585","BK4551","PCSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649564670","title":"GRAIL (GRAL) Could Be 5% Overvalued Following Trial Miss And Class Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2649564670","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649564670?lang=en_us&edition=fundamental","pubTime":"2026-07-07 08:32","pubTimestamp":1783384358,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) stock has been in focus after the company disclosed that its NHS-Galleri trial did not meet the primary endpoint in reducing late stage cancers, triggering sharp losses and a wave of securities class action lawsuits.\nSee our latest analysis for GRAIL.\nSince that disclosure and the resulting securities class actions, GRAIL’s share price has seen a 14.95% 1 month share price return and a 40.28% 3 month share price return. The 1 year total shareholder return is 53.73%, suggesting...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-could-be-5-overvalued-following-trial-miss-and-cl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524361","title":"When Multi-cancer Blood Screens Could Finally Take Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524361?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:02","pubTimestamp":1782943320,"startTime":"0","endTime":"0","summary":"Investors have waited with varying levels of patience for multi-cancer screening tests to lift off toward a targeted $30 billion to $50 billion in annual volume. Sales this year from the blood tests w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABT","LU0106261612.USD","LU1989763427.SGD","GH","LU0963586101.USD","SG9999002224.SGD","LU2211815571.USD","LU1061106388.HKD","SG9999004303.SGD","LU2264538146.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE0002141913.USD","SGXZ41872573.SGD","LU2089984988.USD","LU2237957811.SGD","BK4592","LU0882574055.USD","LU0109394709.USD","SG9999002232.USD","LU2324357040.USD","BK4139","LU0868494617.USD","LU2065171402.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2065171311.SGD","BK4566","BK4504","LU0058720904.USD","LU0122379950.USD","LU0345770993.USD","LU1023059063.AUD","LU2065169927.USD","BK4581","LU1691799644.USD","BK4196","LU1721429741.USD","LU0889565916.HKD","BK4585","BK4535","GRAL","LU0114720955.EUR","LU0266013472.USD","BK4551","LU1989763690.USD","LU0170899867.USD","NTRA","LU2133065610.SGD","LU1914381329.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646580378","title":"Grail Partners with Samsung C&T to Commercialize Galleri Cancer Test in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2646580378","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646580378?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:13","pubTimestamp":1782393226,"startTime":"0","endTime":"0","summary":"Grail partners with Samsung C&T to commercialize Galleri cancer test in South KoreaGrail entered a planned commercial collaboration with Samsung C&T to launch the Galleri multi-cancer early detection ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL8qJ9H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646803220","title":"Grail Rises as $110 Mln Samsung-backed Funding Boosts Cancer Test Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2646803220","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646803220?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:12","pubTimestamp":1782393170,"startTime":"0","endTime":"0","summary":"BUZZ-Grail rises as $110 mln Samsung-backed funding boosts cancer test expansion** Shares of GrailGRAL.Orise 6.2% to $68.58 premarket** The cancer test maker says it raised $110 mln via equity sale to Samsung affiliates to support growth and global expansion** Adds that investment was priced at $70.05 per share** Notes partnership with Samsung C&T aims to bring Galleri cancer screening test to South Korea and potentially to Japan and Singapore** Galleri screens for over 50 cancers, including some without routine tests, company said** Testing initially to be done in North Carolina lab - GRAL** Test not approved by U.S. FDA and does not detect all cancers, GRAIL adds** As of last close, stock down ~25% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4N42X1A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646803951","title":"Grail Closes USD 110 Million Equity Financing with Samsung Affiliates at USD 70.05 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646803951","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646803951?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:01","pubTimestamp":1782392501,"startTime":"0","endTime":"0","summary":"Grail closes USD 110 million equity financing with Samsung affiliates at USD 70.05 a shareSamsung affiliates invested USD 110 million in Grail via a common-stock purchase priced at USD 70.05 per share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL1xwBG4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646803692","title":"Grail Completes $110 Million Equity Financing with Samsung Entities","url":"https://stock-news.laohu8.com/highlight/detail?id=2646803692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646803692?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:00","pubTimestamp":1782392404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUAY99VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646031548","title":"Press Release: GRAIL Completes $110 Million Equity Financing with Samsung Entities","url":"https://stock-news.laohu8.com/highlight/detail?id=2646031548","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646031548?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:00","pubTimestamp":1782392400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., June 25, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the closing of its prev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","BK4504","BK4232","IEMG","BK4139","R","EMXC","BK4084","BK4585","BK4550","BK4588","BK4533","BK4581","PSA","BK4022","CLIA","BK4217","GRAL","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070242","title":"Grail shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070242?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:50","pubTimestamp":1782161456,"startTime":"0","endTime":"0","summary":"Grail held its annual shareholder meeting on June 18, 2026.Shareholders selected two Class II directors, with Sarah Krevans, Steven Mizell set to serve through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL4KLGwg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644201034","title":"GRAIL (GRAL) Is Up 6.0% After NHS-Galleri Trial Misses Endpoint And Lawsuits Filed - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2644201034","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644201034?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:41","pubTimestamp":1781822499,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. has now disclosed that its large NHS-Galleri trial failed to meet its primary endpoint of reducing late-stage cancers, and multiple law firms have filed securities class actions alleging the company misled investors about the study’s prospects and design.\nThe lawsuits center on claims that management overstated the likelihood of success within the trial’s three-year timeframe and selectively withheld adverse information, raising fresh questions about both the evidentiary basis...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-up-60-after-nhs-galleri-trial-misses-endpoint","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-up-60-after-nhs-galleri-trial-misses-endpoint","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641196798","title":"Grail (GRAL) Valuation Check As ASCO 2026 Galleri Data Lifts Early Cancer Detection Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2641196798","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641196798?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:27","pubTimestamp":1780622842,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) is back in focus after unveiling detailed PATHFINDER 2 and NHS-Galleri data at ASCO 2026, highlighting early cancer detection gains and a low false positive rate when its Galleri test is used as a complement to standard screening.\nSee our latest analysis for GRAIL.\nThose ASCO results have arrived alongside a sharp move in the stock, with a 1-day share price return of 8.87% and a 30-day share price return of 22.33%. However, the year-to-date share price return is still down...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-asco-2026-galleri-data-lifts-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-valuation-check-as-asco-2026-galleri-data-lifts-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640918249","title":"How GRAIL’s (GRAL) Galleri Trial Data Could Reframe Its Multi-Cancer Screening Investment Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2640918249","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640918249?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:20","pubTimestamp":1780521648,"startTime":"0","endTime":"0","summary":"At the 2026 ASCO meeting, GRAIL reported full NHS-Galleri and PATHFINDER 2 results showing its Galleri blood test increased screen-detected cancers and reduced late-stage diagnoses when added to standard screenings in large North American and UK populations.\nThe data highlighted high specificity, relatively strong positive predictive value, and accurate cancer signal origin detection, suggesting Galleri could materially change how health systems approach multi-cancer screening while...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/how-grails-gral-galleri-trial-data-could-reframe-its-multi-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/how-grails-gral-galleri-trial-data-could-reframe-its-multi-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640929598","title":"Grail files initial beneficial ownership statement for Chief Growth Officer Andrew Partridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2640929598","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640929598?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:52","pubTimestamp":1780437146,"startTime":"0","endTime":"0","summary":"Grail Chief Growth Officer Andrew John Partridge filed an initial beneficial ownership report showing 165,229 shares of common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL510SrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640910034","title":"Piper Sandler Remains a Hold on GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640910034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640910034?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:59","pubTimestamp":1780401544,"startTime":"0","endTime":"0","summary":"In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on GRAIL Inc, with a price target of $56.00. Westenberg co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-hold-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-hold-on-grail-inc-gral-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640753962","title":"Grail assumed with a Peer Perform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640753962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640753962?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:52","pubTimestamp":1780347166,"startTime":"0","endTime":"0","summary":"Wolfe Research assumed coverage of Grail (GRAL) with a Peer Perform rating and no price target The company need payor support to scale, says Wolfe,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-assumed-with-a-peer-perform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-assumed-with-a-peer-perform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640177966","title":"Sector Update: Healthcare Stocks Fall in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640177966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640177966?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:49","pubTimestamp":1780336181,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Monday afternoon, with the NYSE Healthcare Index falling 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.4%.The iShares Biotechnology ETF (IBB)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0390134368.USD","LU0238689110.USD","LU0417517546.SGD","SG9999014013.SGD","LU0211331839.USD","BK4154","HCSG","BK4539","HUM.AU","XLV","LU0256863811.USD","BK4566","LU0208291251.USD","BK7500","SG9999014005.SGD","LU0070302665.USD","LU0348723411.USD","LU1093756325.SGD","LU0128526141.USD","LU0029874061.USD","LU1983260115.SGD","LU1093756168.USD","BK4533","EWTX","BK4585","LU0170899867.USD","LU0266013472.USD","XBI","BK7093","GRAL","BK4581","HUM","BK4588","LABU","JSPR","BK4139","BK4007","IBB","SG9999014021.USD","BK4137","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966951","title":"BUZZ-U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966951","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640966951?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:40","pubTimestamp":1780335647,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL6N4290OW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4562","GRAL","BK4615","KSS","SPCE","LU2065169927.USD","BK4103","BK4139","LU2065171311.SGD","BK4187","BK4585","BK4220","LU2065170008.USD","BK4588","LU2065171402.SGD","BK4547","BK4564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640855965","title":"Grail falls -18.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640855965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640855965?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:10","pubTimestamp":1780330237,"startTime":"0","endTime":"0","summary":"Grail (GRAL) is down -18.4%, or -$13.18 to $58.50. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-falls-18-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-falls-18-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.2215},{"period":"3month","weight":0.4044},{"period":"6month","weight":-0.249},{"period":"1year","weight":1.0217},{"period":"ytd","weight":-0.1515}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAIL, Inc.(GRAL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}